People suffering from the autoimmune disease lupus might soon have a new drug to turn to, a clinical trial suggests.
Anifrolumab is a lab-created antibody that blocks type 1 interferon, a biochemical that activates an immune response in humans, explained lead researcher Eric Morand, head of the Monash Health School of Clinical Sciences in Melbourne, Australia.
One in three people with lupus uses opioid painkillers even though there is little evidence that they reduce the pain of rheumatic diseases, a new study finds.
"Rheumatic diseases, such as lupus, are a leading cause of chronic pain," said lead author Emily Somers. She's an associate professor of rheumatology, environmental health sciences, and obstetrics and gynecology at Michigan Med...
A new survey shows that rheumatic diseases can be crippling both physically and financially as patients struggle to live with the debilitating conditions.
According to the U.S. Centers for Disease Control and Prevention, 54 million U.S. adults and as many as 300,000 children are living with a rheumatic disease. This includes conditions such as rheumatoid arthritis, lupus, gout, osteoa...
Deaths and complications among pregnant women with lupus have declined in the United States over the past two decades, a new study finds.
Lupus, also called systemic lupus erythematosus (SLE), is a chronic autoimmune disease that causes inflammation in many parts of the body, including the kidneys, skin and joints, as well as the tissue lining the lungs, heart and brain.